The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

EDMONTON, Alberta--(BUSINESS WIRE)--NanoSpeed Diagnostics, Inc. (“NanoSpeed”) is pleased to announce an expansion of their exclusive distribution agreement with global diagnostics and instrumentation ...

DiaSys Corporation, a US-based healthcare products company, plans to further develop its three-year sales and service agreement with the Istanbul-based Ekin Medical, a Turkish diagnostics company.

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

WATERBURY, Conn.--(BUSINESS WIRE)--Sept. 25, 2003--DiaSys Corporation (AMEX:DYX), a global healthcare products company, today announced that it had made an exclusive three-year distributor sales ...

Explore DIASYS CORP by DiaSys Corp. stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for DYXC.

The Union Budget contains details about the estimated receipts and the expenditure of the government for a particular fiscal year. The Budget is allotted for the upcoming fiscal year, which runs from ...

New Delhi: Fair trade regulator CCI today approved acquisition of Piramal Enterprises' lab diagnostics and point-of-care business by DiaSys India. In 2014, Ajay Piramal-led Piramal Enterprises Ltd ...

DiaSys is an owner-managed medium-sized medical technology company and has a presence across Europe, Asia and Latin America. The deal signed on Monday will allow DiaSys to establish its presence in ...

DiaSys Corp. operates as a health card company engaged in the design, development, manufacture and distribution of workstation instruments, consumables, reagents and specialized test kits to hospital, ...

Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.